360 related articles for article (PubMed ID: 26247590)
1. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity.
Ristić GG; Subota V; Lepić T; Stanisavljević D; Glišić B; Ristić AD; Petronijević M; Stefanović DZ
PLoS One; 2015; 10(8):e0130462. PubMed ID: 26247590
[TBL] [Abstract][Full Text] [Related]
2. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.
Daza L; Aguirre M; Jimenez M; Herrera R; Bollain JJ
Clin Rheumatol; 2007 Apr; 26(4):533-7. PubMed ID: 16758372
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment.
Ristić GG; Lepić T; Glisić B; Stanisavljević D; Vojvodić D; Petronijević M; Stefanović D
Rheumatology (Oxford); 2010 Jun; 49(6):1076-81. PubMed ID: 20208070
[TBL] [Abstract][Full Text] [Related]
4. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.
Ambrosino P; Lupoli R; Di Minno A; Tasso M; Peluso R; Di Minno MN
Thromb Haemost; 2015 May; 113(5):916-30. PubMed ID: 25716931
[TBL] [Abstract][Full Text] [Related]
5. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
[TBL] [Abstract][Full Text] [Related]
6. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
[TBL] [Abstract][Full Text] [Related]
7. Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients.
Pereira IA; Laurindo IM; Zimmermann AF; Werner Castro GR; Mello F; Borba EF
Acta Reumatol Port; 2009; 34(1):58-64. PubMed ID: 19449480
[TBL] [Abstract][Full Text] [Related]
8. Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis.
Montes A; Corrales A; Calaza M; Lopez-Mejias R; Parra JA; González-Gay MA; González A
Arthritis Rheumatol; 2015 Nov; 67(11):2861-5. PubMed ID: 26246227
[TBL] [Abstract][Full Text] [Related]
9. [Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis].
Gobbi CA; Asbert P; Alba PB; Resk J; Dotto G; Demarchi M; Cuvertino E; Pepe GA; Salica DA; Albiero EH; Martínez F
Rev Fac Cien Med Univ Nac Cordoba; 2019 Aug; 76(3):174-179. PubMed ID: 31465186
[TBL] [Abstract][Full Text] [Related]
10. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular diseases in rheumatoid arthritis].
Popkova TV; Khelkovskaia AN; Mach ES; Aleksandrova EN; Novikov AA; Novikova DS; Nasonov EL
Ter Arkh; 2007; 79(5):9-14. PubMed ID: 17672067
[TBL] [Abstract][Full Text] [Related]
12. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media.
Gerli R; Sherer Y; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():281-90. PubMed ID: 16126969
[TBL] [Abstract][Full Text] [Related]
13. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
[TBL] [Abstract][Full Text] [Related]
14. Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study.
Veselinovic M; Jakovljevic V; Jurisic-Skevin A; Toncev S; Djuric DM
Clin Rheumatol; 2012 Dec; 31(12):1727-32. PubMed ID: 22960771
[TBL] [Abstract][Full Text] [Related]
15. Is small artery elasticity decreased prior to intima-media thickening in patients with longstanding rheumatoid arthritis?
Hinkema HJ; Nienhuis HL; de Groot L; Smit AJ; van Roon AM; Bijl M; Posthumus MD
J Rheumatol; 2011 Oct; 38(10):2133-40. PubMed ID: 21844153
[TBL] [Abstract][Full Text] [Related]
16. Serum pentraxin 3 and interleukin-6 are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis.
Mabrouk MM; Ghazy MA; Hassan TM
Egypt J Immunol; 2010; 17(1):87-99. PubMed ID: 22053612
[TBL] [Abstract][Full Text] [Related]
17. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
Spinelli FR; Pecani A; Ciciarello F; Colasanti T; Di Franco M; Miranda F; Conti F; Valesini G; Alessandri C
BMC Musculoskelet Disord; 2017 May; 18(1):214. PubMed ID: 28545441
[TBL] [Abstract][Full Text] [Related]
18. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis.
del Rincón I; Polak JF; O'Leary DH; Battafarano DF; Erikson JM; Restrepo JF; Molina E; Escalante A
Ann Rheum Dis; 2015 Jun; 74(6):1118-23. PubMed ID: 24845391
[TBL] [Abstract][Full Text] [Related]
20. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
